Position
Pfizer Inc in Allogene Therapeutics, Inc.
Back to the book · All holders of ALLO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $19.6M$1.37 → $2.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 22M | $30.2M | — | — | — | 12.8% |
| Q1 2026 | 22M | $49.8M | $2.26 | $19.6M | $0 | 20.9% |